期刊
JOURNAL OF CONTROLLED RELEASE
卷 327, 期 -, 页码 397-405出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2020.08.013
关键词
Biologics; Co-formulation; Combination therapy; Synergistic benefit; Protein; Nucleic acid; Vaccine
资金
- Engineering and Physical Sciences Research Council [EP/R025282/1]
- Nottingham Research Fellowship from the University of Nottingham
- BBSRC [BB/R012415/1] Funding Source: UKRI
- EPSRC [EP/R025282/1, EP/P006485/1] Funding Source: UKRI
Biologic therapeutics are the medicines of the future and are destined to transform the approaches by which the causes and symptoms of diseases are cured and alleviated. These approaches will be accelerated through the development of novel strategies that target multiple pharmacologically active sites using a combination of different biologics, or mixtures of biologics and small molecule therapeutics. However, for this potential to be realised, advancements in co-formulation strategies for biologic therapeutics must be established. This review describes the current and emerging developments within this field and highlights the challenges and potential solutions, that will pave-the-way towards their clinical translation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据